Hypothesis / aims of study
Introduction
Synthetic mesh for treatment of stress urinary incontinence can be associated with exposure into the vagina and extrusion into the urinary tract (1). Magnetic resonance imaging (MRI) and ultrasound imaging using the trans-rectal (TRUS) or transvaginal approach can diagnose some mesh complications and contribute to the diagnostic pathway for women alongside examination under anaesthesia and cysto-urethroscopy.
Aims of study
The aim of this retrospective study is to assess the diagnostic accuracy of MRI and TRUS in detecting mesh complications amongst our cohort of women.
At this present time, there is limited evidence regarding the efficacy of TRUS, and with little to no published data regarding MRI (2).
Study design, materials and methods
A retrospective analysis was performed of all women who had surgical removal of continence mesh or a formal examination under anaesthetic in our Urology unit from 2018 to 2021. MRI and TRUS imaging reports were compared to ‘gold standard’ definitive diagnosis in theatre to determine the detection rate of vaginal exposure, urethral and bladder extrusion of each imaging modality.
Interpretation of results
TRUS and pelvic MRI showed similar detection rates of 71.4% and 80% respectively in the diagnosis of urethral extrusion. Amongst the 5 women with bladder extrusion who had TRUS, detection rate was 1/5 (20%). In contrast, MRI detected 5/6 cases of bladder extrusion. There were no ‘false positive’ MRIs or TRUS findings.